DOSING DETAILS   

Study Dosing Objective:  Effective Dose, Safety Profile,

Established Protocol:  No effective dose

Route of Administration: 

Cannabinoid Ratio:  (THC : CBD)   63 : 80    

Dosage Form:  capsules that contained 150 mg of cannabis (Bediol), these capsules could be placed in a hand-held vaporizer, 6.3% THC (9.5 mg) and 8% CBD (12 mg)

Dosing Regimen:  Three groups: - 5 mg oxycodone tablets (max. four times/day), - 150 mg of inhaled cannabis containing 6.3% Δ9-tetrahydrocannabinol and 8% cannabidiol (max. times inhalation sessions/day) - a combination of both

Treatment Duration:  for 6 weeks

Clinical Relevance:  Cannabis was not more effective than oxycodone for chronic pain of fibromyalgia, and had worse side-effects.

Adverse Events:  sleepiness, headache, insomnia, dizziness, constipation, paranoia and hallucinations, drug high, vomiting

Citation: